Literature DB >> 29509115

Delayed referral of patients with diabetic foot ulcers across Europe: patterns between primary care and specialised units.

Chris Manu1, Elisabetta Lacopi2, Benjamin Bouillet3, Julien Vouillarmet4, Raju Ahluwalia1, Claas Lüdemann5, José Luis Garcia-Klepzig6, Marco Meloni7, Víctor Rodriguez-Saenz De Buruaga8, Juan Pedro Sánchez-Ríos9, Mike Edmonds1, Jan Apelqvist10, José Luis Lázaro-Martínez11, Kristien Van Acker12.   

Abstract

OBJECTIVE: Diabetic foot ulceration (DFU) has the potential to deteriorate rapidly without prompt assessment and treatment. The aim of this study was to assess the referral patterns for DFU, from primary care to specialised diabetes foot care units.
METHOD: A two-part, quantitative, online questionnaire was administered to GPs across four countries in Europe: France, the UK, Germany and Spain. The first part entailed a survey of GPs' perceptions of referrals for DFU. The second part of the questionnaire collected data on recently managed DFU cases.
RESULTS: There were 600 questionnaires collected in the first part of the study (150 per country), and 1188 patient cases of DFU management were included in the second part. Up to 95% of patients had type 2 diabetes. Patients' complaints led to diagnosis, on average, 60% of the time, and the diagnosis was an incidental finding during a consultation 13-28% of the time. On average, only 40% of GPs completely agreed that they have clearly identified DFU clinical practitioners working in a hospital facility. In 55-66% of cases, the duration of DFU was unknown or DFU diagnosis was delayed more than three weeks from the onset of the wound. On average, 48% of patients were referred after an unknown duration or more than one month from the onset of DFU.
CONCLUSION: Despite differences in health-care structures across Europe, delays in referral to specialist foot care teams seems to be a common theme. There is an ongoing need to educate GPs, nurses and patients to be more aware of the risk of DFU, and the need for prompt referral to specialist diabetic foot teams.

Entities:  

Keywords:  Europe; diabetic foot; primary care; referral; ulceration

Mesh:

Year:  2018        PMID: 29509115     DOI: 10.12968/jowc.2018.27.3.186

Source DB:  PubMed          Journal:  J Wound Care        ISSN: 0969-0700            Impact factor:   2.072


  6 in total

1.  Electrospun Nanofibers for Wound Management.

Authors:  Johnson V John; Alec McCarthy; Anik Karan; Jingwei Xie
Journal:  ChemNanoMat       Date:  2021-11-01       Impact factor: 3.820

2.  Surgical management of the acute severely infected diabetic foot - The 'infected diabetic foot attack'. An instructional review.

Authors:  R S Ahluwalia; I L H Reichert
Journal:  J Clin Orthop Trauma       Date:  2021-04-24

3.  Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trials.

Authors:  Rakesh Sharma; Suresh K Sharma; Shiv Kumar Mudgal; Prasuna Jelly; Kalpana Thakur
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

4.  The analysis for time of referral to a medical center among patients with diabetic foot infection.

Authors:  Cheng-Wei Lin; Hui-Mei Yang; Shih-Yuan Hung; I-Wen Chen; Yu-Yao Huang
Journal:  BMC Fam Pract       Date:  2021-01-09       Impact factor: 2.497

5.  Effectiveness of fast-track pathway for diabetic foot ulcerations.

Authors:  Marco Meloni; Jose Luis Lazaro-Martínez; Raju Ahluwalia; Benjamin Bouillet; Valentina Izzo; Michela Di Venanzio; Elisabetta Iacopi; Chris Manu; José Luis Garcia-Klepzig; Juan Pedro Sánchez-Ríos; Claas Lüedemann; Víctor Rodriguez-Saenz De Buruaga; Julien Vouillarmet; Jérôme Guillaumat; Anna Rita Aleandri; Laura Giurato; Micheal Edmonds; Alberto Piaggesi; Kristien Van Acker; Luigi Uccioli
Journal:  Acta Diabetol       Date:  2021-05-03       Impact factor: 4.280

6.  Fast-track pathway for diabetic foot ulceration during COVID-19 crisis: A document from International Diabetic Foot Care Group and D-Foot International.

Authors:  Marco Meloni; Benjamin Bouillet; Raju Ahluwalia; Claas Lüdemann; Juan Pedro Sánchez-Ríos; Elisabetta Iacopi; José Luis Lazaro-Martinez
Journal:  Diabetes Metab Res Rev       Date:  2020-08-25       Impact factor: 8.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.